Analyze Diet
The Journal of veterinary medical science2008; 70(6); 623-625; doi: 10.1292/jvms.70.623

Epidemic of equine influenza among vaccinated racehorses in Japan in 2007.

Abstract: On August 2007, we encountered equine influenza epidemic by Florida sub-lineage strain (H3N8) in Japan Racing Association's facilities where 4142 racehorses in total were stabled. The number of new febrile cases sharply increased, but the occurrence was rapidly calmed down within 2 weeks. The morbidity rate in these facilities was 12.8% and the subclinical infection rate of healthy racehorses examined by rapid antigen detection tests was 19.4% at the early stage of epidemic. The serological studies along with the low morbidity rate and the existence of numbers of asymptomatically infected racehorses, suggested that the cross-reactivity of the antibodies provided by vaccination against the epidemic strain contributed to reducing the morbidity rate and duration of epidemic.
Publication Date: 2008-07-17 PubMed ID: 18628606DOI: 10.1292/jvms.70.623Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study reports an outbreak of equine influenza caused by a Florida sub-lineage strain among racehorses in Japan in 2007. It indicates that the immunity provided by vaccination helped reduce the severity and duration of the epidemic.

Introduction & Background

  • The paper discusses an equine influenza epidemic that occurred in Japan Racing Association’s facilities in August 2007. The outbreak was caused by the H3N8 subtype of the virus, commonly known as the Florida sub-lineage strain.
  • A total of 4142 racehorses were stabled at the facilities during the outbreak. The number of new cases involving fever rose sharply, however, the spread of the virus was quickly controlled within two weeks.

Research Findings

  • The researchers determined the morbidity rate in the affected facilities was 12.8% – this is the proportion of horses that displayed symptoms of the disease.
  • Using rapid antigen detection tests, they established a subclinical infection rate of 19.4% in healthy racehorses at the early stage of the epidemic. This means nearly one-fifth of the horses that did not show any clinical symptoms were still infected with the virus.

Serological Studies

  • Through serological studies, which involved the testing of the horses’ blood serum for antibodies against the influenza virus, the researchers found evidence of vaccination-induced immunity against the epidemic strain.
  • This cross-reactivity of the antibodies, i.e. their ability to respond to multiple strains of the virus due to similarities in their structures, suggested that vaccination helped in reducing the morbidity rate and shortening the duration of the epidemic.

Summary

  • The paper suggests that the presence of numerous asymptomatic infections along with the low morbidity rate provides proof that the antibodies conferred by vaccination offered some degree of protection against the epidemic strain of the virus.
  • Therefore, while the antibodies couldn’t completely prevent infection, they presumably limited the severity of the symptoms and helped decrease the spread of the virus, thus contributing to the quick resolution of the epidemic.

Cite This Article

APA
Yamanaka T, Niwa H, Tsujimura K, Kondo T, Matsumura T. (2008). Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. J Vet Med Sci, 70(6), 623-625. https://doi.org/10.1292/jvms.70.623

Publication

ISSN: 0916-7250
NlmUniqueID: 9105360
Country: Japan
Language: English
Volume: 70
Issue: 6
Pages: 623-625

Researcher Affiliations

Yamanaka, Takashi
  • Epizootic Research Center, Equine Research Institute, Japan Racing Association, Tochigi, Japan. takashi_yamanaka@jra.go.jp
Niwa, Hidekazu
    Tsujimura, Koji
      Kondo, Takashi
        Matsumura, Tomio

          MeSH Terms

          • Animals
          • Computational Biology
          • Disease Outbreaks / veterinary
          • Horse Diseases / epidemiology
          • Horses
          • Influenza A Virus, H3N8 Subtype
          • Japan / epidemiology
          • Orthomyxoviridae Infections / epidemiology
          • Orthomyxoviridae Infections / veterinary
          • Reverse Transcriptase Polymerase Chain Reaction
          • Serology
          • Viral Vaccines

          Citations

          This article has been cited 37 times.
          1. Pellegrini F, Buonavoglia A, Omar AH, Diakoudi G, Lucente MS, Odigie AE, Sposato A, Augelli R, Camero M, Decaro N, Elia G, Bányai K, Martella V, Lanave G. A Cold Case of Equine Influenza Disentangled with Nanopore Sequencing. Animals (Basel) 2023 Mar 24;13(7).
            doi: 10.3390/ani13071153pubmed: 37048408google scholar: lookup
          2. Rozario C, Martínez-Sobrido L, McSorley HJ, Chauché C. Could Interleukin-33 (IL-33) Govern the Outcome of an Equine Influenza Virus Infection? Learning from Other Species. Viruses 2021 Dec 15;13(12).
            doi: 10.3390/v13122519pubmed: 34960788google scholar: lookup
          3. Olguin-Perglione C, Barrandeguy ME. An Overview of Equine Influenza in South America. Viruses 2021 May 12;13(5).
            doi: 10.3390/v13050888pubmed: 34065839google scholar: lookup
          4. Wilson A, Pinchbeck G, Dean R, McGowan C. Equine influenza vaccination in the UK: Current practices may leave horses with suboptimal immunity. Equine Vet J 2021 Sep;53(5):1004-1014.
            doi: 10.1111/evj.13377pubmed: 33124070google scholar: lookup
          5. Cullinane A, Gahan J, Walsh C, Nemoto M, Entenfellner J, Olguin-Perglione C, Garvey M, Huang Fu TQ, Venner M, Yamanaka T, Barrandeguy M, Fernandez CJ. Evaluation of Current Equine Influenza Vaccination Protocols Prior to Shipment, Guided by OIE Standards. Vaccines (Basel) 2020 Feb 29;8(1).
            doi: 10.3390/vaccines8010107pubmed: 32121419google scholar: lookup
          6. Blanco-Lobo P, Rodriguez L, Reedy S, Oladunni FS, Nogales A, Murcia PR, Chambers TM, Martinez-Sobrido L. A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus. Viruses 2019 Oct 11;11(10).
            doi: 10.3390/v11100933pubmed: 31614538google scholar: lookup
          7. Gahan J, Garvey M, Asmah Abd Samad R, Cullinane A. Whole Genome Sequencing of the First H3N8 Equine Influenza Virus Identified in Malaysia. Pathogens 2019 May 10;8(2).
            doi: 10.3390/pathogens8020062pubmed: 31083430google scholar: lookup
          8. Toh X, Soh ML, Ng MK, Yap SC, Harith N, Fernandez CJ, Huangfu T. Isolation and characterization of equine influenza virus (H3N8) from an equine influenza outbreak in Malaysia in 2015. Transbound Emerg Dis 2019 Sep;66(5):1884-1893.
            doi: 10.1111/tbed.13218pubmed: 31059176google scholar: lookup
          9. Miño S, Mojsiejczuk L, Guo W, Zhang H, Qi T, Du C, Zhang X, Wang J, Campos R, Wang X. Equine Influenza Virus in Asia: Phylogeographic Pattern and Molecular Features Reveal Circulation of an Autochthonous Lineage. J Virol 2019 Jul 1;93(13).
            doi: 10.1128/JVI.00116-19pubmed: 31019053google scholar: lookup
          10. Singh RK, Dhama K, Karthik K, Khandia R, Munjal A, Khurana SK, Chakraborty S, Malik YS, Virmani N, Singh R, Tripathi BN, Munir M, van der Kolk JH. A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies. Front Microbiol 2018;9:1941.
            doi: 10.3389/fmicb.2018.01941pubmed: 30237788google scholar: lookup
          11. Gildea S, Garvey M, Lyons P, Lyons R, Gahan J, Walsh C, Cullinane A. Multifocal Equine Influenza Outbreak with Vaccination Breakdown in Thoroughbred Racehorses. Pathogens 2018 Apr 17;7(2).
            doi: 10.3390/pathogens7020043pubmed: 29673169google scholar: lookup
          12. Nemoto M, Yamanaka T, Bannai H, Tsujimura K, Kokado H. Complete Genomic Sequences of H3N8 Equine Influenza Virus Strains Used as Vaccine Strains in Japan. Genome Announc 2018 Mar 22;6(12).
            doi: 10.1128/genomeA.00172-18pubmed: 29567739google scholar: lookup
          13. Rodriguez L, Reedy S, Nogales A, Murcia PR, Chambers TM, Martinez-Sobrido L. Development of a novel equine influenza virus live-attenuated vaccine. Virology 2018 Mar;516:76-85.
            doi: 10.1016/j.virol.2018.01.005pubmed: 29331866google scholar: lookup
          14. Yamanaka T, Nemoto M, Bannai H, Tsujimura K, Matsumura T, Kokado H, Gildea S, Cullinane A. Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan. J Vet Med Sci 2018 Mar 2;80(2):382-386.
            doi: 10.1292/jvms.17-0538pubmed: 29237998google scholar: lookup
          15. Gahan J, Garvey M, Gildea S, Gür E, Kagankaya A, Cullinane A. Whole-genome sequencing and antigenic analysis of the first equine influenza virus identified in Turkey. Influenza Other Respir Viruses 2018 May;12(3):374-382.
            doi: 10.1111/irv.12485pubmed: 28940727google scholar: lookup
          16. Yamanaka T, Nemoto M, Bannai H, Tsujimura K, Kondo T, Matsumura T, Fu TQH, Fernandez CJ, Gildea S, Cullinane A. Rapid diagnosis of equine influenza by highly sensitive silver amplification immunochromatography system. J Vet Med Sci 2017 Jun 16;79(6):1061-1063.
            doi: 10.1292/jvms.17-0105pubmed: 28458275google scholar: lookup
          17. Rash A, Morton R, Woodward A, Maes O, McCauley J, Bryant N, Elton D. Evolution and Divergence of H3N8 Equine Influenza Viruses Circulating in the United Kingdom from 2013 to 2015. Pathogens 2017 Feb 8;6(1).
            doi: 10.3390/pathogens6010006pubmed: 28208721google scholar: lookup
          18. Gamoh K, Nakamura S. Update of inactivated equine influenza vaccine strain in Japan. J Vet Med Sci 2017 Mar 23;79(3):649-653.
            doi: 10.1292/jvms.16-0558pubmed: 28163276google scholar: lookup
          19. Meseko CA, Ehizibolo DO, Nwokike EC, Wungak YS. Serological evidence of equine influenza virus in horse stables in Kaduna, Nigeria. J Equine Sci 2016;27(3):99-105.
            doi: 10.1294/jes.27.99pubmed: 27703404google scholar: lookup
          20. Barba M, Daly JM. The Influenza NS1 Protein: What Do We Know in Equine Influenza Virus Pathogenesis?. Pathogens 2016 Aug 31;5(3).
            doi: 10.3390/pathogens5030057pubmed: 27589809google scholar: lookup
          21. Yamanaka T, Nemoto M, Bannai H, Tsujimura K, Kondo T, Matsumura T, Gildea S, Cullinane A. Assessment of antigenic difference of equine influenza virus strains by challenge study in horses. Influenza Other Respir Viruses 2016 Nov;10(6):536-539.
            doi: 10.1111/irv.12418pubmed: 27465864google scholar: lookup
          22. Paillot R, El-Hage CM. The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary. Pathogens 2016 Jun 10;5(2).
            doi: 10.3390/pathogens5020042pubmed: 27294963google scholar: lookup
          23. Alves Beuttemmüller E, Woodward A, Rash A, Dos Santos Ferraz LE, Fernandes Alfieri A, Alfieri AA, Elton D. Characterisation of the epidemic strain of H3N8 equine influenza virus responsible for outbreaks in South America in 2012. Virol J 2016 Mar 19;13:45.
            doi: 10.1186/s12985-016-0503-9pubmed: 26993620google scholar: lookup
          24. Yamanaka T, Nemoto M, Bannai H, Tsujimura K, Kondo T, Matsumura T, Gildea S, Cullinane A. Evaluation of twenty-two rapid antigen detection tests in the diagnosis of Equine Influenza caused by viruses of H3N8 subtype. Influenza Other Respir Viruses 2016 Mar;10(2):127-33.
            doi: 10.1111/irv.12358pubmed: 26568369google scholar: lookup
          25. Perglione CO, Gildea S, Rimondi A, Miño S, Vissani A, Carossino M, Cullinane A, Barrandeguy M. Epidemiological and virological findings during multiple outbreaks of equine influenza in South America in 2012. Influenza Other Respir Viruses 2016 Jan;10(1):37-46.
            doi: 10.1111/irv.12349pubmed: 26406274google scholar: lookup
          26. Paillot R. A Systematic Review of Recent Advances in Equine Influenza Vaccination. Vaccines (Basel) 2014 Nov 14;2(4):797-831.
            doi: 10.3390/vaccines2040797pubmed: 26344892google scholar: lookup
          27. Kim EJ, Kim BH, Yang S, Choi EJ, Shin YJ, Song JY, Shin YK. Antibody responses after vaccination against equine influenza in the Republic of Korea in 2013. J Vet Med Sci 2015 Nov;77(11):1517-21.
            doi: 10.1292/jvms.15-0192pubmed: 26062436google scholar: lookup
          28. Andersson MG, Faverjon C, Vial F, Legrand L, Leblond A. Using Bayes' rule to define the value of evidence from syndromic surveillance. PLoS One 2014;9(11):e111335.
            doi: 10.1371/journal.pone.0111335pubmed: 25364823google scholar: lookup
          29. Muranaka M, Yamanaka T, Katayama Y, Niwa H, Oku K, Matsumura T, Oyamada T. Time-related Pathological Changes in Horses Experimentally Inoculated with Equine Influenza A Virus. J Equine Sci 2012;23(2):17-26.
            doi: 10.1294/jes.23.17pubmed: 24833992google scholar: lookup
          30. Bera BC, Virmani N, Shanmugasundaram K, Vaid RK, Singh BK, Gulati BR, Anand T, Barua S, Malik P, Singh RK. Genetic Analysis of the Neuraminidase (NA) Gene of Equine Influenza Virus (H3N8) from Epizootic of 2008-2009 in India. Indian J Virol 2013 Sep;24(2):256-64.
            doi: 10.1007/s13337-013-0137-0pubmed: 24426284google scholar: lookup
          31. Gildea S, Fitzpatrick DA, Cullinane A. Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010-2012). Influenza Other Respir Viruses 2013 Dec;7 Suppl 4(Suppl 4):61-72.
            doi: 10.1111/irv.12192pubmed: 24224821google scholar: lookup
          32. Yamanaka T, Tsujimura K, Kondo T, Matsumura T, Ishida H, Kiso M, Hidari KI, Suzuki T. Infectivity and pathogenicity of canine H3N8 influenza A virus in horses. Influenza Other Respir Viruses 2010 Nov;4(6):345-51.
          33. Cullinane A, Elton D, Mumford J. Equine influenza - surveillance and control. Influenza Other Respir Viruses 2010 Nov;4(6):339-44.
          34. Bryant NA, Paillot R, Rash AS, Medcalf E, Montesso F, Ross J, Watson J, Jeggo M, Lewis NS, Newton JR, Elton DM. Comparison of two modern vaccines and previous influenza infection against challenge with an equine influenza virus from the Australian 2007 outbreak. Vet Res 2010 Mar-Apr;41(2):19.
            doi: 10.1051/vetres/2009067pubmed: 19863903google scholar: lookup
          35. Nemoto M, Kawanishi N, Kambayashi Y, Bannai H, Yamanaka T, Garvey M, Cullinane A, Yamayoshi S, Kawaoka Y, Tsujimura K. Growth properties of recombinant equine influenza viruses with different backbones generated by reverse genetics in embryonated chicken eggs. Arch Virol 2025 Jul 12;170(8):181.
            doi: 10.1007/s00705-025-06368-5pubmed: 40646296google scholar: lookup
          36. Zhang Y, Guo X, Yu M, Sun L, Qu Y, Guo K, Hu Z, Liu D, Zhang H, Wang X. Equine ANP32 proteins support influenza A virus RNA polymerase activity. Virol Sin 2023 Oct 27;38(6):951-60.
            doi: 10.1016/j.virs.2023.10.009pubmed: 39491182google scholar: lookup
          37. Lim SI, Kim MJ, Kim MJ, Lee SK, Yang HS, Kwon M, Lim EH, Ouh IO, Kim EJ, Hyun BH, Lee YH. Assessment of Equine Influenza Virus Status in the Republic of Korea from 2020 to 2022. Viruses 2023 Oct 23;15(10).
            doi: 10.3390/v15102135pubmed: 37896912google scholar: lookup